We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Five-Marker Panel Helps Diagnose Lupus

By LabMedica International staff writers
Posted on 17 Jan 2012
A five-marker panel was designed to Rule-In Systemic Lupus Erythematosus (SLE) and Rule-Out other rheumatic diseases to help establish an accurate SLE diagnosis.

Called Avise SLE, the panel includes testing of antinuclear antibodies (ANA), anti-double stranded DNA antibodies (dsDNA), anti-mutated citrullinated vimentin antibodies (Avise MCV), EC4d, and BC4d. More...
The cell-bound complements rule-in SLE because of their increased performance over soluble complements, which help to accurately and consistently diagnose SLE.

ANA, dsDNA, and AntiMCV are measured using enzyme-linked immunosorbent assay (ELISA) whereas EC4d and BC4d are measured using flow cytometry. A negative result for ANA helps rule-out the possibility of SLE. A positive result for dsDNA rules-in SLE. AVISE MCV rules-out Rheumatoid Arthritis.

Exagen Diagnostics, Inc. (Albuquerque, NM, USA), a specialty focused molecular diagnostics laboratory that discovers, develops and markets proprietary tests for rheumatologists and gastroenterologists, launched the Avise SLE, which aids in the diagnosis of lupus (Systemic Lupus Erythematosus).

The serological and flow cytometric tests are performed using a standard blood specimen, and shipped to Exagen's specialized Clinical Laboratory Improvement Amendments (CLIA) registered, College of American Pathologists (CAP) certified laboratory for processing. The company provides kits, pays shipping costs, and returns test results in 7 business days

Related Links:

Exagen Diagnostics, Inc.




Gold Member
Veterinary Hematology Analyzer
Exigo H400
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Integrated Biochemical & Immunological System
Biolumi CX8
New
Automated Microscope
dIFine
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: New research brings hope for improved early detection of pancreatic cancer (Photo courtesy of Adobe Stock)

New Biomarker Panel to Enable Early Detection of Pancreatic Cancer

Pancreatic cancer (PC) has one of the worst prognoses globally, with only 13% of diagnosed patients surviving for five years or more. In Ireland, there are about 900 cases of pancreatic cancer annually,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.